Bristol-Myers Squibb Co.'s board elected José Baselga as a director, effective March 1.
Baselga is currently serving as physician-in-chief at New York-based Memorial Sloan Kettering Cancer Center.
Bristol-Myers Squibb board elects director
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Bristol-Myers Squibb Co.'s board elected José Baselga as a director, effective March 1.
Baselga is currently serving as physician-in-chief at New York-based Memorial Sloan Kettering Cancer Center.